Intervention not reported
Oliguria (Urine output < 1 mL/kg/hour) · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in oliguria (Urine output < 1 mL/kg/hour) (low certainty).
1 finding from 1 review
Intervention not reported
Failure to close a patent ductus arteriosus after 3 doses of ibuprofen · preterm infants with patent ductus arteriosus
The intervention probably leads to lower failure to close a patent ductus arteriosus after 3 doses of ibuprofen (moderate certainty).
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in necrotising enterocolitis (low certainty).
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in necrotising enterocolitis (moderate certainty).
1 finding from 1 review
Intervention not reported
Oliguria · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in oliguria (low certainty).
1 finding from 1 review
Intervention not reported
Failure to close a patent ductus arteriosus (PDA) (after single or 3 doses) · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in failure to close a patent ductus arteriosus (PDA) (after single or 3… (moderate certainty).
1 finding from 1 review
Intervention not reported
Need for surgical closure of the PDA · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in need for surgical closure of the PDA (moderate certainty).
1 finding from 1 review
Intervention not reported
Duration of ventilator support (days) · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in duration of ventilator support (days) (moderate certainty).
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis (any stage) · preterm infants with patent ductus arteriosus
The intervention probably leads to lower necrotising enterocolitis (any stage) (moderate certainty).
1 finding from 1 review
Intervention not reported
Oliguria (urine output < 1 mL/kg/hour) · preterm infants with patent ductus arteriosus
The intervention probably leads to lower oliguria (urine output < 1 mL/kg/hour) (moderate certainty).
1 finding from 1 review
Intervention not reported
Serum/plasma creatinine levels (μmol/L) · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in serum/plasma creatinine levels (μmol/L) (low certainty).
1 finding from 1 review
Intervention not reported
Failure to close a patent ductus arteriosus (PDA) (after 3 doses) · preterm infants with patent ductus arteriosus
The intervention showed no clear difference in failure to close a patent ductus arteriosus (PDA) (after 3 doses) (low certainty).
1 finding from 1 review
Intervention not reported
Need for surgical closure of PDA (during hospital stay) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
The intervention probably leads to lower need for surgical closure of PDA (during hospital stay) (moderate certainty).
1 finding from 1 review
Intervention not reported
IVH grade III to IV (during hospital stay) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
The intervention showed no clear difference in IVH grade III to IV (during hospital stay) (moderate certainty).
1 finding from 1 review
Intervention not reported
NEC (during hospital stay) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
The intervention showed no clear difference in NEC (during hospital stay) (moderate certainty).
1 finding from 1 review
Intervention not reported
Gastrointestinal haemorrhage (during hospital stay) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
The intervention may leads to higher gastrointestinal haemorrhage (during hospital stay) (low certainty).
1 finding from 1 review
Intervention not reported
Oliguria (during ibuprofen treatment) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
The intervention leads to higher oliguria (during ibuprofen treatment) (high certainty).
1 finding from 1 review
Intervention not reported
Serum creatinine levels (mg/dL) (after treatment) Normal values for male and female newborns (17.7 to 88.4 µmol/L) (0.23 to 1.16 mg/dL) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
1 finding from 1 review
Intervention not reported
Gastrointestinal haemorrhage (during hospital stay) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life
The intervention may leads to higher gastrointestinal haemorrhage (during hospital stay) (low certainty).
1 finding from 1 review
Intervention not reported
Use of 1 or more red blood cell transfusions (low and high doses of EPO) · preterm infants with low birth weight
The intervention may leads to lower use of 1 or more red blood cell transfusions (low and high doses of… (low certainty).
1 finding from 1 review